An experimental study found that serum ET-1 levels in individuals arriving quickly at a plateau from the plains or low altitudes were significantly increased.[22] The increase in ET-1 is considered a pathogenetic mechanism of hypoxic pulmonary hypertension,[23,24] and it plays a role in the development of AMS. The gene discussed is EDN1; the disease is ablepharon macrostomia syndrome.